Ads
related to: hiv, hepatitis
Search results
Gilead Sciences, Inc. (GILD) to Issue Quarterly Dividend of $0.77 on June 27th
ETF DAILY NEWS· 2 days agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) announced a quarterly dividend on Tuesday, April 23rd, Zacks reports. Stockholders of record on Friday, June 14th will be paid a dividend ...
Westwood Holdings Group Inc. Has $104.61 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoWestwood Holdings Group Inc. trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the fourth quarter, according to the company in its most recent Form 13F filing ...
Campbell & CO Investment Adviser LLC Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoCampbell & CO Investment Adviser LLC raised its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 19.1% in the 4th quarter, Holdings Channel.com reports. The firm owned ...
Shell Asset Management Co. Has $7.17 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 4 days agoShell Asset Management Co. decreased its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 18.4% in the 4th quarter, according to the company in its most recent disclosure with the ...
EHP Funds Inc. Sells 10,200 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 4 days agoEHP Funds Inc. lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 68.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund ...
Connectus Wealth LLC Sells 640 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 4 days agoConnectus Wealth LLC trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent filing with the ...
Sei Investments Co. Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 4 days agoSei Investments Co. trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC.